Astero

A Review and Case Study of Astero®  (Lidocaine HCl 4%), a New Prescription Hydrogel for Painful Wounds

A Review and Case Study of Astero® (Lidocaine HCl 4%), a New Prescription Hydrogel for Painful Wounds

By Marc A. Brenner, DPM | Podiatry Management, Clinical Innovations, The Diabetic Foot.
Wound pain has numerous, often interlinked, causes that may relate to the initial injury, the inflammatory response or infection. Pain may also result from interventions, such as dressing removal, cleansing, debridement, compression therapy, or topical treatments. Pain as a result of trauma, particularly during the dressing change procedure, has been described by patients as the worst part of dealing with a wound.1

MDose v Tube Study

MDose v Tube Study

MDose™ Technology Background It has been shown that convenience, ease of dispensing and favorable tolerability are key characteristics that may increase patient compliance with topical dermatologic therapy.[1],[2],[3] Additionally, the quantity of drug utilized with...
Medicare (CGDP) Gap Announcement

Medicare (CGDP) Gap Announcement

Gensco Pharma Announces Additions to 2017 CGDP on CMS Gensco products will be available to MEDICARE patients in 2017              

Supply Partners

Gensco Pharma is a FDA licensed pharmaceutical manufacturer focusing on the research, development and marketing of transdermal prescription products. As an innovator of pharmaceutical products, Gensco Pharma currently delivers non-narcotic transdermal analgesic gels...
Got Pain?

Got Pain?

Transdermal Pharmaceuticals Clinically Proven APPA | September 2016 Chain Drug Review | July 2016 Chain Drugstore Daily | April 2016